Trial of MR-guided Focused Ultrasound (MRgFUS) Bilateral Capsulotomy for the Treatment of Refractory Obsessive-compulsive Disorder (OCD)

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 20, 2017

Primary Completion Date

November 18, 2020

Study Completion Date

October 20, 2021

Conditions
Obsessive-Compulsive Disorder
Interventions
DEVICE

Focused Ultrasound

MR-guided Focused Ultrasound (MRgFUS) offers the possibility of lesioning deep brain targets, while obviating the need for open surgical approaches. There is no radiation, incision, or burr hole, and lesions are generated in real-time under MR image guidance. Intracranial FUS for other applications, essential tremor most notably, has been shown to be safe and effective, recently receiving Health Canada approval for this indication. The technology, methods and procedures used in this study are identical to those in essential tremor.

Trial Locations (2)

T2N 2T9

Foothill Medical Centre, Calgary

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
collaborator

Hotchkiss Brain Institute, University of Calgary

OTHER

lead

Sunnybrook Health Sciences Centre

OTHER

NCT03156335 - Trial of MR-guided Focused Ultrasound (MRgFUS) Bilateral Capsulotomy for the Treatment of Refractory Obsessive-compulsive Disorder (OCD) | Biotech Hunter | Biotech Hunter